Evidence map›Paper›PMID 40474233›Full record

ArticleJournal of orthopaedic surgery and research2025

Sympathetic cholinergic nerve fibres promote BMSC differentiation into osteoblasts via NRTN secretion: a potential treatment for osteoporosis.

Yuechun Chen, Zhenyu Zhang, Huibo Ti, Junjie Wu, Feng-Lai Yuan, Xia Li

Abstract read
In one paragraph

Article in Journal of orthopaedic surgery and research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yuechun Chen *Institute of Integrated Chinese and Western Medicine, Affiliated Hospital of Jiangnan University, Wuxi, 343099, Jiangsu Province, China.
Zhenyu Zhang *Department of Food Science and Engineering, Jiangnan University, Wuxi, 214028, Jiangsu Province, China.
Huibo Ti, Wuxi, China.
Junjie WuInstitute of Integrated Chinese and Western Medicine, Affiliated Hospital of Jiangnan University, Wuxi, 343099, Jiangsu Province, China.
Feng-Lai YuanInstitute of Integrated Chinese and Western Medicine, Affiliated Hospital of Jiangnan University, Wuxi, 343099, Jiangsu Province, China.
Xia LiDepartment of Pharmacy, Affiliated Hospital of Jiangnan University, Wuxi, 343099, Jiangsu Province, China. lixia.ahmu.cn@163.com.

Funding

Foundation for Innovative Research Groups of the National Natural Science Foundation of China 82372412
6 · The paper itself

Abstract

backgroundPeripheral nerves within the bone actively participate in bone remodelling by secreting various bioactive molecules, and dysfunction or changes in their abundance greatly contribute to the onset of osteoporosis. While it is well established that sympathetic adrenergic nerve fibres reduce bone mass and contribute to osteoporosis, the role of sympathetic cholinergic signalling in this condition is still poorly understood. We aimed to investigate whether sympathetic cholinergic nerve fibres influence osteoporosis through the secretion of neurturin (NRTN).

methodsA mouse model of osteoporosis was established via bilateral ovariectomy (OVX). Differences in cholinergic signalling and NRTN expression levels between sham-operated control mice and OVX mice were assessed using methods such as quantitative real-time polymerase chain reaction, Western blotting, enzyme-linked immunosorbent assay, and immunofluorescence staining. The effects of NRTN on bone mass and bone formation were examined in vivo through micro-computed tomography analysis, bone morphometric analysis, histological analysis, and immunohistochemistry staining. In vitro, clone formation assay, tartrate-resistant acid phosphatase staining, alkaline phosphatase staining, and alizarin red S staining were employed to validate the impacts of NRTN on osteoblast proliferation, osteoclast differentiation, and osteoblast differentiation.

resultsSympathetic cholinergic signalling was diminished in OVX mice, coinciding with a decrease in the neurotrophic factor, NRTN, which is secreted by sympathetic cholinergic nerve endings. NRTN treatment resulted in a dose-dependent increase in bone mass in OVX mice. Subsequent investigations confirmed that NRTN promotes bone formation in vivo and enhances the differentiation of bone marrow mesenchymal stem cells into osteoblasts in vitro.

conclusionsOur results suggest that sympathetic cholinergic nerve fibres promote bone mass through NRTN secretion, providing new insights into potential therapeutic strategies for osteoporosis.

Indexed as

Cell DifferentiationCholinergic FibersMesenchymal Stem CellsNeurturinOsteoblastsOsteoporosisSympathetic Nervous SystemAnimalsCells, CulturedDisease Models, AnimalFemaleMiceMice, Inbred C57BLOvariectomyNeurturinNrtn protein, mouseBone remodellingCholinergic signallingMesenchymal stem cellsNeurturinOsteoblast differentiationOsteoporosisSympathetic nerves

Identifiers

PMID40474233
PMCPMC12139376

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.